ENCOMPASS HEALTH REHABILITATION HOSP
1. Target Overview & Investment Thesis
ENCOMPASS HEALTH REHABILITATION HOSP is a 60-bed suburban community hospital in MERCER, WV with $23.9M in net patient revenue and a 23.8% operating margin. The hospital serves a payer mix of 69.8% Medicare, 0.7% Medicaid, and 29.5% commercial.
Thesis: Turnaround. Our ML models identify $1.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 23.8% to 31.2% (+736bps).
| Net Revenue HCRIS | $23.9M |
| Current EBITDA COMPUTED | $5.7M |
| Operating Margin COMPUTED | 23.8% |
| Occupancy HCRIS | 65.3% |
| Revenue / Bed COMPUTED | $398K |
| Net-to-Gross HCRIS | 73.0% |
| Distress Probability ML | 51.4% |
2. Market Context & Competitive Position
WV has 62 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 23.8% places it above the state median. Among 20 size-comparable peers (30-120 beds), the median margin is 4.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (30-120), prioritizing same-state peers. 20 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ENCOMPASS HEALTH REHABILITATIO (Target) | WV | 60 | $23.9M | 23.8% |
| PRINCETON COMMUNITY HOSPITAL | WV | 115 | $290.2M | 12.8% |
| REYNOLDS MEMORIAL HOSPITAL | WV | 94 | $123.6M | 3.8% |
| BECKLEY ARH | WV | 72 | $109.2M | -37.8% |
| DAVIS MEMORIAL HOSPITAL | WV | 90 | $100.9M | -20.4% |
| ST FRANCIS HOSPITAL | WV | 40 | $58.5M | 30.5% |
| GREENBRIER VALLEY MEDICAL CENT | WV | 58 | $50.8M | 4.3% |
| ENCOMPASS HEALTH REHABILITATIO | WV | 96 | $47.0M | 15.6% |
| PLEASANT VALLEY HOSPITAL | WV | 49 | $39.9M | -48.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $501K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $477K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $472K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $290K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $15K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $5.7M |
| + RCM Uplift | +$1.8M |
| Pro Forma EBITDA | $7.4M |
| Current Margin | 23.8% |
| Pro Forma Margin | 31.2% |
| WC Released (1x) | $915K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $8.7M | $55.1M | 6.30x | 44.5% |
| Base (11x exit) | 10.0x | 11.0x | $8.7M | $63.4M | 7.25x | 48.6% |
| Bull Case | 9.0x | 11.0x | $7.9M | $72.0M | 9.15x | 55.7% |
| Bull (12x exit) | 9.0x | 12.0x | $7.9M | $80.9M | 10.28x | 59.4% |
| Bear Case | 11.0x | 10.0x | $9.6M | $43.4M | 4.52x | 35.2% |
| Bear (11x exit) | 11.0x | 11.0x | $9.6M | $50.9M | 5.29x | 39.6% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Heavy Medicare dependence | Medicare comprises 69.8% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
| High | Elevated distress probability | Model estimates 51.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 20 hospitals with 30-120 beds
- Same-state prioritization (n=21)
- Comp margins: P25=-14.0% / P50=4.3% / P75=12.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.